ArticleInternational urology and nephrology2022

Risk factors for failure of long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign prostatic enlargement.

Naoki Wada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.